Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-09-19
2006-09-19
Canella, Karen A. (Department: 1643)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S021800
Reexamination Certificate
active
07109159
ABSTRACT:
The use of leptin and leptin-related molecules in oncology is disclosed.
REFERENCES:
patent: 5756461 (1998-05-01), Stephens
Rubinstein et al, “Leptin inhibits growth factor induced cell proliferation.” Cytokine, vol. 9, No. 11, p. 953, Abstract 253, Nov. 1997.
Jackson, JG and White MF, “Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-1 . . . ” J. of Biological Chemistry, vol. 273, No. 16, pp. 9994-10003, Apr. 1998.
Bjorbaek et al, “Divergent Signaling Capacities of the Long and short Isoforms of the Leptin Receptor.”, J or Biological Chemistry, vol. 272, No. 51, pp. 32686-32695, Dec. 1997.
Bowie et al “Deciphering the Message in protein Sequences:Tolerance to Amino Acid substitutions” Science, vol. 247, pp. 1306-1310, 1990.
Lazar et al, “Transforming Growth Factor Alpha: Mutation of Aspartic Acid 47 and Leuine 48 Results in Different Biological Activities”, Molecular and Cellular Biology, vol. 8, pp. 1247-1252, 1988.
Burgess et al “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a single Lysine Residue”, Journal of Cellular biology, vol. 111, pp., 1990.
P. Bork, “Power and pitfalls in sequenc analysis”, Genome Research, vol. 10, pp. 398-400, 2000.
Gura, T. “systems for identifying new drugs are often faulty”, Science, vol. 278, pp. 1041-1042, Nov. 1997.
Jain, R., “Barriers to drug delivery in solid tumors”, Scientific American, vol. 271, pp. 58-65, Jul. 1994.
Curti, B., “Physical Barriers to drug delivery in tumors”, Critical Reviews in Oncology/Hematology, vol. 14, pp. 29-39, 1993.
Hartwell et al, “Integrating genetic approaches into the discovery of anticancer drugs”, Scienc , vol. 278, pp. 1064-1068, Nov. 1997.
Mathews and Van Holde, Biochemistry (textbook), 2nd edition, pp. 165-171, 1996.
B. Matthews, “Genetic and Structural analysis of the protein stability problem”, in Perspectives in Biochemistry, vol. 1, pp. 6-9, 1989.
Rubinstein et al, Cytokine, 1997, vol. 9, pp. 953, abstract only.
Moro et al, Journal of biological chemistry, 1999, vol. 274, pp. 23103-23110. (abstract).
Tanaka et al (Journal of Biological Chemistry, Jun. 14, 1996, vol. 24, pp. 14610-14616).
The abstract of Stevenson et al (Proc Annu Meet Am Assoc Cancer Res, 1996, vol. 37, p. A375).
Clark et al (International Journal of Cancer, 1996, vol. 65, pp. 186-191).
Carter et al (U.S. Patent Application 2002193571, priority to Jan. 7, 1997).
Abstract of Sastry et al (International Journal of Cancer, Jan. 17, 1997, vol. 70, No. 2, pp. 208-213).
Abstract of Janes et al (Oncogene, Dec. 1994, vol. 9, No. 12, pp. 3601-3608).
Abstract of Fiddes et al (Cell Growth and Differentiation, 1995, vol. 6, No. 12, pp. 1567-1577).
Abstract of Ito et al (Molecular and Cellular Biology, 1996, vol. 16, No. 3, pp. 943-951).
Zachow et al., Direct Intraovarian Effects of Leptin: Impairment of the Synergistic Action of Insulin-like Growth Factor-I on Follicle-Stimulating Hormone-Dependent Estradiol-17 Production by Rat Ovarian Granulosa Cells,“Endocrinology”, vol. 138, No. 2, pp. 847-850, (1997).
Barkan et al., “Leptin Inhibits Growth-Factor-Induced Cell Proliferation”,Chemical Abstracts, pp. 953, (1997).
Barkan Dalit
Cohen Batya
Rubinstein Menachem
Canella Karen A.
Yeda Research and Development Co. Ltd.
LandOfFree
Leptin as an inhibitor of tumor cell proliferation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leptin as an inhibitor of tumor cell proliferation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leptin as an inhibitor of tumor cell proliferation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3553083